| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 09/12/2013 | US20130236498 Biodegradable supporting device |
| 09/12/2013 | US20130236404 Substances and compositions for enhancing dna repair and methods of use |
| 09/11/2013 | EP2636736A1 Novel anti-dr5 antibody |
| 09/11/2013 | EP2636677A1 Cdk-inhibiting pyrrolopyrimidinone carboxamide derivative or pharmaceutically acceptable salt thereof, and pharmaceutical composition containing same as active ingredient for preventing or treating liver cell cancer |
| 09/11/2013 | EP2636673A1 Aminomethylene pyrazolones with therapeutic activity |
| 09/11/2013 | EP2636672A1 Imidazole derivatives and preparation method and use thereof |
| 09/11/2013 | EP2636667A1 Benzamide derivative with anticancer activity and preparation method and use thereof |
| 09/11/2013 | EP2636410A1 Utilization of the dichlorido complexes of platinum with 7-azaindole halogeno-derivatives for the preparation of drugs for the treatment of tumour diseases |
| 09/11/2013 | EP2635607A1 Stable heterodimeric antibody design with mutations in the fc domain |
| 09/11/2013 | EP2635605A1 Anti-her3 antibodies and compositions |
| 09/11/2013 | EP2635604A2 Pan-her antibody composition |
| 09/11/2013 | EP2635603A1 C-met antibody combinations |
| 09/11/2013 | EP2635602A1 Anti c-met antibodies |
| 09/11/2013 | EP2635587A1 Novel 6-arylamino pyridone carboxamide as mek inhibitors |
| 09/11/2013 | EP2635579A1 Synthetic lethality in cancer |
| 09/11/2013 | EP2635578A1 2-arylimidazo[1,2-b]pyridazine, 2-phenylimidazo[1,2-a]pyridine, and 2-phenylimidazo[1,2-a]pyrazine derivatives |
| 09/11/2013 | EP2635575A1 Carbazole and carboline derivatives, and preparation and therapeutic applications thereof |
| 09/11/2013 | EP2635574A1 1h-pyrrolo[2,3-b]pyridine derivatives |
| 09/11/2013 | EP2635569A1 Crystalline forms of ( s ) - 2 - amino - 3 - (4 - ( 2 - amino - 6 - ( (r) - 1 - (4 - ch loro-2- (3 -methyl- 1h- pyrazol- 1 -yl) phenyl) - 2, 2, 2 - trifluoroethoxy) pyrimidin- 4 - yl) phenyl) propanoic acid |
| 09/11/2013 | EP2635566A1 Benzimidazole inhibitors of leukotriene production |
| 09/11/2013 | EP2635565A1 5 -cyano-4, 6 -diaminopyrimidine or 6 -aminopurine derivatives as pi3k- delta inhibitors |
| 09/11/2013 | EP2635562A1 Pyrrolidine derivatives used as cathepsin inhibitors |
| 09/11/2013 | EP2635558A1 Process for preparing bendamus tine hydrochloride monohydrate |
| 09/11/2013 | EP2635557A2 Nicotinamides as jak kinase modulators |
| 09/11/2013 | EP2635308A2 Compositions of a peptide targeting system for treating cancer |
| 09/11/2013 | EP2635306A1 Microsphere comprising a lanthanide metal complex |
| 09/11/2013 | EP2635300A1 Dock-and-lock (dnl) constructs for human immunodeficiency virus (hiv) therapy |
| 09/11/2013 | EP2635294A1 Immunotherapy against erbb-3 receptor |
| 09/11/2013 | EP2635289A1 Peg or peg block copolymers for treating colorectal cancer |
| 09/11/2013 | EP2635288A1 Treatment of pituitary corticotroph tumors using r-roscovitine |
| 09/11/2013 | EP2635287A1 Administration of nedd8-activating enzyme inhibitor |
| 09/11/2013 | EP2635284A1 Heterocyclic compounds and uses thereof |
| 09/11/2013 | EP2635279A2 Chemical compounds |
| 09/11/2013 | EP2635273A2 Isoflavonoid compositions and methods for the treatment of cancer |
| 09/11/2013 | EP2635262A2 System and method for delivery of dna-binding chemotherapy drugs using nanoparticles |
| 09/11/2013 | EP2635121A1 Isoflavonoid compounds and methods for the treatment of cancer |
| 09/11/2013 | EP2205257B1 LAG-3Ig (IPM321) dosage regimes for use in the treatment of cancer |
| 09/11/2013 | CN1842603B Method of selecting wt1 vaccine adaptive patient |
| 09/11/2013 | CN1665807B Novel physiolgically active substances |
| 09/11/2013 | CN103298928A Method for activating helper t cell |
| 09/11/2013 | CN103298834A Dual variable domain immunoglobulins and uses thereof |
| 09/11/2013 | CN103298831A NK cell modulating treatments and methods for treatment of hematological malignancies |
| 09/11/2013 | CN103298818A Spiro-oxindole MDM2 antagonists |
| 09/11/2013 | CN103298817A Novel sulfamide piperazine derivatives as protein tyrosine kinase inhibitors and pharmaceutical use thereof |
| 09/11/2013 | CN103298816A Substituted pyrazolo-quinazoline derivatives as kinase inhibitors |
| 09/11/2013 | CN103298814A 2-anilinopurin-8-ones as inhibitors of TTK/MPS1 for the treatment of proliferative disorders |
| 09/11/2013 | CN103298808A Novel ureas for the treatment and prevention of cancer |
| 09/11/2013 | CN103298806A Substituted pyridazine carboxamide compounds |
| 09/11/2013 | CN103298805A Quinazoline compounds and methods of use thereof |
| 09/11/2013 | CN103298803A Substituted pyridazine carboxamide compounds as kinase inhibitor compounds |
| 09/11/2013 | CN103298795A Pure intermediate for preparing letrozole |
| 09/11/2013 | CN103298788A Pyridine derivative and medicinal agent |
| 09/11/2013 | CN103298787A 3-(aminoaryl)-pyridine compounds |
| 09/11/2013 | CN103298488A Peptide or peptide complex binding to 2 integrin and methods and uses involving the same |
| 09/11/2013 | CN103298487A Companion animal treatments |
| 09/11/2013 | CN103298481A Use of prolactin receptor antagonist and chemotherapeutic drug for treating ovarian cancer |
| 09/11/2013 | CN103298471A Use of imidazoquinolines for the treatment of EGFR dependent diseases or diseases that have acquired resistance to agents that target EGFR family members |
| 09/11/2013 | CN103298465A Uses of cimiracemate and related compounds for treating inflammation and modulating immune responses |
| 09/11/2013 | CN103298461A Methods of treating tumors |
| 09/11/2013 | CN103293316A A method of diagnosis and treatment |
| 09/11/2013 | CN103290112A Application of CCDC158 gene in preparation of liver cancer treatment or diagnosis medicament |
| 09/11/2013 | CN103290101A Ago2 gene and application of expression product thereof |
| 09/11/2013 | CN103290029A Survivin promoter mediated recombinant vector for expressing Gelonin phytotoxin genes and usage thereof |
| 09/11/2013 | CN103290018A Nucleic acid aptamer specifically bound with human epidermal growth factor receptor III-type mutant and application of nucleic acid aptamer |
| 09/11/2013 | CN103290017A HER2 (Human Epidermal Growth Factor Receptor 2) protein nucleotide aptamer, complex composition and applications thereof |
| 09/11/2013 | CN103289980A Protease screening methods and proteases indentified thererby |
| 09/11/2013 | CN103289957A Methods and kit for preparing stem cell-like lung cancer cells and loading dendritic cells on antigen composition thereof |
| 09/11/2013 | CN103289097A Pluronic-modified PAMAM (polyamide-amine) graft polymer and application |
| 09/11/2013 | CN103289082A Block copolymer and preparation method thereof |
| 09/11/2013 | CN103288981A Sulphated heparan sulfated for inhibiting cell proliferation |
| 09/11/2013 | CN103288968A An anti-tumor targeting complex and a preparation method and applications thereof |
| 09/11/2013 | CN103288966A Fusion receptor and gene medicine thereof for treating colorectal cancer |
| 09/11/2013 | CN103288958A A single chain antibody against a cancer stem cell-specific protein CD44 and applications thereof |
| 09/11/2013 | CN103288957A Antibody drug derivative inhibiting tumor growth, its preparation method and use |
| 09/11/2013 | CN103288931A Immunogenic polypeptides for human papillomavirus as well as preparation method and application of same |
| 09/11/2013 | CN103288928A Bacillus mojavensis, antifungal lipopeptide compound, and preparation as well as application thereof |
| 09/11/2013 | CN103288926A Tubulin polymerization agent polypeptide and application thereof |
| 09/11/2013 | CN103288920A Survivin-derived peptide and use thereof |
| 09/11/2013 | CN103288916A Derivatives of tanshinone compounds as well as synthesis method and application thereof |
| 09/11/2013 | CN103288913A Novel compound, pharmaceutical compositions thereof as well as preparation methods thereof and use of novel compound and pharmaceutical compositions |
| 09/11/2013 | CN103288912A Salts of buxus microphylla base derivative |
| 09/11/2013 | CN103288911A Bufalin glycosylation derivative and preparation method and application thereof in preparation of anti-tumour medicaments |
| 09/11/2013 | CN103288910A Extracting method of diranopteris dichotoma rear-earth complex with anti-tumor effect |
| 09/11/2013 | CN103288881A Dual-core organic metal ruthenium compound with anti-tumor activity |
| 09/11/2013 | CN103288880A Semi-sandwich type dual-core organic metal ruthenium compound with anti-tumor activity |
| 09/11/2013 | CN103288868A Dibutyltin 4-tert-butyl-benzoate with tin and oxygen heterocycle structure as well as preparation method and application of dibutyltin 4-tert-butyl-benzoate |
| 09/11/2013 | CN103288858A 2-phenyl pyridyl ketoxime copper compound as well as preparation method and application thereof |
| 09/11/2013 | CN103288847A Preparation method and use of compound comprising benzo spiroketal and benzo bridged cycloketal |
| 09/11/2013 | CN103288842A Fluoro-substituted E cyclocamptothecin analogues and use thereof as drug |
| 09/11/2013 | CN103288840A Phthalocyanine-erlotinib yoke compound and preparation and application thereof |
| 09/11/2013 | CN103288835A Inhibitors of E1 activating enzyme |
| 09/11/2013 | CN103288833A Imidazo triazines and imidazo pyrimidines as kinase inhibitors |
| 09/11/2013 | CN103288827A Preparation method and activity of novel indole quinazoline alkaloid |
| 09/11/2013 | CN103288824A Tetrahydropyridopyridone derivative as well as preparation method and application thereof |
| 09/11/2013 | CN103288823A N,N'-aryl substituted urea compound and application thereof |
| 09/11/2013 | CN103288819A Salt of crinum asiaticum novacine derivative |
| 09/11/2013 | CN103288818A Anti-cancer drug based on benziso-selenazolone as well as preparation method and application thereof |
| 09/11/2013 | CN103288815A Beta-lactamyl vasopression V1a antagonists |
| 09/11/2013 | CN103288807A Alkaloid separated from Tripterygium wilfordii endophytic fungus metabolite and application thereof |
| 09/11/2013 | CN103288805A Benzofuran-containing pyrimidine compound, its preparation method and use |